Yes.Is it time to worry now?
This year really flew by, didn't it? I'm sure the next few will too.
Yes.Is it time to worry now?
@BadNeighbors, it is likely that Innovation Partnership is no longer the sole investor at this point. It seems Auricle was trying to attract additional investment back in 2021, based on this video:I still believe that since the University of Michigan owns the patent for this device, their Innovation Partnership might be leading efforts to bring it to market.
However, I worry that, like many university departments, the University of Michigan's Innovation Partnership is severely underfunded and understaffed. This is a press release the Innovation Partnership released last year about the device.
The funding situation for university inventions looks dismal. For example, their "up to $250,000 for mid-stage funding" program is a drop in the bucket. To put that into perspective, my company spent a minimum of $25 million per year, and likely closer to $200 million, developing an all-digital application over two years. A device like this should have at least a few million dollars behind it. A small startup of 12 people could easily burn through $250,000 in just a few weeks.
I also think organizations like Spotify, Capitol Records, or others in the music industry could easily pitch in funding. They would stand to gain goodwill with musicians and fans who suffer from tinnitus. The minimal funding offered by the university would only make sense if it functions like the Bipartisan Infrastructure Law, offering support to somewhat risky but potentially profitable technologies to encourage private investment. It cannot be the primary investment itself; it must serve as a seal of approval to signal to real investors that this project is worth supporting. I wonder how much we would need as angel investors to influence the University of Michigan and get this moving.
Another thought: Does Tim Walz know about this device? Regardless of politics, he is a well-known figure, a veteran suffering from tinnitus, and the governor of a state renowned for its medical innovation. See this and this for context. While governors do not hand out grants, Walz's network could help connect Dr. Shore's device with medical investors, companies, and individuals who could accelerate its development. Why are we not lobbying him? We should all be camping outside his office to get a few minutes of his time and make him aware of this device.
The lack of awareness is a real issue. If the last three audiologists I visited, including one who is a professor, were unaware of Dr. Shore's device, I doubt Walz knows about it either.
I pray we see any type of treatment that actually works.My daughter was born the year this thread started. I pray we see this come out before she goes to college...
Looking glum.I've been out of the loop on this for a while. What do we think now? 2030? 2050?
I'm going to assume this is due to the less-than-ideal results of Lenire.Looking glum.
I wonder if we can still get in on the ground floor, either as individuals or as a group.@BadNeighbors, it is likely that Innovation Partnership is no longer the sole investor at this point. It seems Auricle was trying to attract additional investment back in 2021, based on this video:
Who knows how successful they were, but it is quite possible that they now have more investors onboard besides Innovation Partnership.
That said, they do seem to be taking their time and only have a couple of employees. This is probably because they do not have enough funding to move faster. However, they would have burned through $250,000 very quickly. There must be more funding in the mix to keep them going.
Lenire and Auricle operate in different ways. Lenire works by increasing hyperactivity in the dorsal cochlear nucleus (DCN) to distract the brain from tinnitus. In contrast, Auricle reduces hyperactivity, aiming to address the underlying issue directly.I'm going to assume this is due to the less-than-ideal results of Lenire.
That's what I'm thinking. Even though the devices are different, the FDA may be more cautious about approving the Shore device after witnessing the failure of Lenire.I'm going to assume this is due to the less-than-ideal results of Lenire.